{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-010729","form_type":"8-K","ticker":"TLPH","cik":"0001427925","company_name":"TALPHERA, INC.","filed_at":"2025-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.265887+00:00","generated_at":"2026-05-23T23:25:02.833585+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Talphera raises $4.9M in first closing of private placement; additional closings contingent on trial enrollment","bullets":["Gross proceeds of ~$4.9M from first closing: 3,405,118 shares and pre-funded warrants for 4,999,316 shares at $0.586/share.","Second closing of ~$4.9M triggered by enrollment of ≥17 patients in Niyad NEPHRO CRRT study and VWAP ≥$0.7325.","Third closing of ~$4.9M triggered by enrollment of ≥35 patients in same study and VWAP ≥$0.7325.","Pre-funded warrants have $0.001 exercise price, unlimited term, and are exercisable immediately at each closing.","Registration rights agreement filed; executive officers and directors subject to 90-day lock-up after effective date."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-010729","json":"https://secwatch.observer/filing/0001437749-25-010729.json","markdown":"https://secwatch.observer/filing/0001437749-25-010729.md","text":"https://secwatch.observer/filing/0001437749-25-010729.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427925/000143774925010729/0001437749-25-010729-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427925/000143774925010729/acrx20250401_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T23:25:02.833585+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}